Abstract
Radiotherapy is one of the main treatments of nasopharyngeal cancer (NPC) and lung cancer. Accurate segmentation of organs at risks (OARs) in CT images is a key step in radiotherapy planning for NPC and lung cancer. However, the segmentation of OARs is influenced by the highly imbalanced size of organs, which often results in very poor segmentation results for small and difficult-to-segment organs. In addition, the complex morphological changes and fuzzy boundaries of OARs also pose great challenges to the segmentation task. In this paper, we propose a cross-layer attention fusion network (CLAF-CNN) to solve the problem of accurately segmentingOARs. In CLAF-CNN, we integrate the spatial attention maps of the adjacent spatial attention modules to make the segmentation targets more accurately focused, so that the network can capture more target-related features. In this way, the spatial attention modules in the network can be learned and optimized together. In addition, we introduce a new Top-K exponential logarithmic Dice loss (TELD-Loss) to solve the imbalance problem in OAR segmentation. The TELD-Loss further introduces a Top-K optimization mechanism based on Dice loss and exponential logarithmic loss, which makes the network pay more attention to small organs and difficult-to-segment organs, so as to enhance the overall performance of the segmentationmodel. We validated our framework on the OAR segmentation datasets of the head and neck and lung CT images in the StructSeg 2019 challenge. Experiments show that the CLAF-CNN outperforms the state-of-the-art attention-based segmentation methods in the OAR segmentation task with average Dice coefficient of 79.65% for head and neck OARs and 88.39% for lungOARs. This work provides a new network named CLAF-CNN which contains cross-layer spatial attention map fusion architecture and TELD-Loss for OAR segmentation. Results demonstrated that the proposed method could obtain accurate segmentation results for OARs, which has a potential of improving the efficiency of radiotherapy planning for nasopharynx cancer and lung cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.